Lori Kim, MD

Research & Grantsmanship 

  Non-Funded Research Project

• 10/2008 H. Lee Moffitt Cancer Center Principal Investigator Retrospective chart review of patients diagnosed with Castleman’s Disease from 2004-2010 at H. Lee Moffitt Cancer Center. ( 10/2008 )

• 8/2005 H. Lee Moffitt Cancer Center Co-Investigator A clinical trial on Sunitinib mesylate (SU11248) in combination with dacarbazine in the treatment of metastatic melanoma. ( 8/2008 )

• 6/2008 H. Lee Moffitt Cancer Center Co-Principal Investigator Phase II study of dasatinib in advanced stage non-small cell lung cancer with assessment of intratumor dasatinib levels and tumor target modulation. ( 6/2008 )

• 10/2005 H. Lee Moffitt Cancer Center Co-Investigator A clinical trial on Sunitinib mesylate (SU11248), a novel antiangiogenic agent in the treatment of metastatic hepatocellular cancer. ( 10/2005 )